期刊文献+

PTD-eGFP-△E250 mFoxp3融合蛋白的表达与穿膜能力鉴定

Express of the PTD-eGFP-△E250 mFoxp3 fusion protein and identification of its transmembrane efficiency and ability
下载PDF
导出
摘要 目的:构建、表达并纯化含有蛋白转导结构域(protein transduction domain,PTD)、eGFP的小鼠Foxp3突变体(PTD-eGFP-△E250 mFoxp3)融合蛋白,为研究小鼠Foxp3的功能奠定基础。方法:利用重叠延伸PCR方法构建pET28a-PTD-eGFP-△E250 mFoxp3原核表达载体,并在大肠埃希菌Rosetta(DE3)中表达此融合蛋白,经Ni2+柱纯化,通过流式细胞仪和激光共聚焦显微镜观察其穿膜效率。结果:成功构建了pET28a-PTD-eGFP-△E250 mFoxp3原核表达载体,并表达和纯化了PTD-eGFP-△E250 mFoxp3融合蛋白,流式细胞仪和激光共聚焦显微镜检测结果显示融合蛋白能很好地穿过细胞膜进入细胞内,并定位于细胞质和细胞核。结论:成功制备了具有穿膜活性的PTD-eGFP-△E250 mFoxp3融合蛋白,为更好地研究小鼠Foxp3的功能与特性奠定了实验基础。 Objective: To express and purify a mutant mouse Foxp3 fusion protein containing a protein transduction domain from TAT and an enhanced green fluorescence protein(PTD-eGFP-△E250 mFoxp3),furthermore to investigate its′s efficiency and ability transmembrane and laid the groundwork for future research about the function of mouse foxp3.Methods: The pET28a-PTD-eGFP-△E250 mFoxp3 vector was constructed by inserting the PCR products of mouse mutant Foxp3 into pET28a-PTD-eGFP vector.The fusion protein was expressed by E.coli Rosetta(DE3) and purified by Bio-Rad Profinity IMAC Ni-charged Resin.The efficiency and ability of transmembrane of PTD-eGFP-△E250 mFoxp3 were detected by FCM and confirmed by confocal microscopy. Results: The vector of pET28a-PTD-eGFP-△E250 mFoxp3 was constructed correctly and the fusion protein was expressed and purified efficiently.The results of FCM and confocal microscopy investigation indicated that PTD-eGFP-△E250 mFoxp3 fusion protein transduce into EL-4 cell efficiently. Conclusion: The PTD-eGFP-△E250 mFoxp3 protein can transduce into cells efficiently and may be a useful tool to study the biological functions of Foxp3.
出处 《江苏大学学报(医学版)》 CAS 2009年第1期14-18,22,F0002,共7页 Journal of Jiangsu University:Medicine Edition
基金 国家自然科学基金资助项目(30671984 30471627 30300169)
关键词 蛋白质转导结构域 FOXP3 突变 穿细胞膜活性 protein transduction domain Foxp3 mutant transmembrane ability
  • 相关文献

参考文献16

  • 1Sakaguchi S. Naturally arising CD4 ^+ regulatory T cells for immunologic self-tolerance and negative control of immune responses[J]. Annul Rev Immunol, 2004,22: 53 1- 562.
  • 2Brunkow ME, Jellbry EW, Hjerrild KA, et al. Disruption of one new fork head/winged-helix protein, scurfin,results in the fatal lympho proliferative disorder of the scurfin mouse[J]. Nat Genet, 2001,27(1 ) :68 -73.
  • 3Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 ^+ CD25 ^+ regulatory T cells[J]. Nat Immunol, 2003, 4(4):330 - 336.
  • 4Khattri R, Cox T, Yasayko SA, et al. An essential role for Scrufin in CD4 ^+ CD25 ^+ regulatory T cells [ J ]. Nat Immunol, 2003, 4 (4) :337 - 342.
  • 5Hori S, Nomura T, Sakaguehi S. Control of regulatory T cells development by the transcription factor Foxp3 [ J ]. Science, 2003, 299(5609) :1057 - 1061.
  • 6Ziegler SF. FOXP3 : of mice and men [ J ]. Annu Rev Immunol, 2006,24:209 - 226.
  • 7Chae WJ, Henegariu O, Lee SK, et al. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells[J]. PNAS, 2006, 103 (25) :9661 -9636.
  • 8Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein [ J ]. Cell, 1988,55 (6) :1179 - 1188.
  • 9Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus[ J]. Cell, 1988,55 (6) :1189 - 1193.
  • 10Vires E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus [J]. J Biol Chem, 1997,272(25):16010- 16017.

二级参考文献9

  • 1Gavin MA,Torqerson TR,Rudensky AY,et al.Single-cell analysis of normal and FOXP3-mutant human T cells:FOXP3 expression without regulatory T cell development[J].Proc Natl Acad Sci USA,2006,103(17):6659-6664.
  • 2Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3[J] Science,2003,299(5609):1057-1061.
  • 3Liu Y,Li JL,Johnny JH.HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa,tip110[J].J Biol Chem,2002,277(26):23854-23863.
  • 4Kathrin R,Loddenkemper C,Maul J,et al.Mucosal FOXP3^+ regulatory T cells are numericallydeficient in acute and chronic GvHD[J].Blood,2006,107(4):1717-1723.
  • 5Sullivan KE,McDonald-McGinn D,Zackai E.CD4^+ CD25^+ T-cell productionin healthy humans and in patients with thymic hypoplasia[J].Clin Diag Lab Immunol,2002,9(5):1129-1131.
  • 6Ochs HD,Ziegler SF,Torgerson TR.FOXP3 acts as a rheostat of the immune response[J].Immunol Rev,2005,203(2):156-164.
  • 7Severine LB,Raif SG.IPEX and the role of Foxp3 in the development and function of human Tregs[J].J Biol Chem,2006,116(6):1473-1475.
  • 8Loser K,Hansen W,Beissert S,et al.In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic auroimmunity[J].Gene Ther,2005,12(17):1294-1304.
  • 9Jaeckel E,Boehmer HV,Manns PM.Antigen-specific Foxp3-transduced T-cells can controlestablished type 1 diabetes[J].Diabetes,2005,54(2):306-310.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部